Clinical trial
Cross-over Analysis of the Control of Coronary Risk Factors and Level of Platelet Inhibition With a Polypill
NCT05030818 is registered in ClinicalTrials.gov with Fundación EPIC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cross-over Analysis of the Control of Coronary Risk Factors and Level of Platelet Inhibition With a Polypill
- Lead sponsor
- Fundación EPIC
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- October 14, 2022
- Completion date
- April 30, 2026
- Enrollment
- 88 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.